Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The GABA-B receptor agonist baclofen helps patients with alcohol use disorder: why these findings matter

Neuropsychopharmacology(2021)10.1038/s41386-021-01142-ySource: DataRank Database

The GABA-B receptor agonist baclofen helps patients with alcohol use disorder: why these findings matter is a research paper published in Neuropsychopharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.97)OA: bronzeTopics (22)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Raye Z. Litten ORCID,Lorenzo Leggio ORCID

Live enrichment

PubMed:34400781 PMC:PMC8581012 OpenAlex:https://openalex.org/W3195978238

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism

FWCI

0.97

Citation Percentile

0.7%

Citation Trend

2022

2024

bronzeLicense: https://www.springer.com/tdm

journalhttps://www.nature.com/articles/s41386-021-01142-y.pdf

publisherhttps://www.nature.com/articles/s41386-021-01142-y.pdf

publisherhttps://www.nature.com/articles/s41386-021-01142-y

journalhttps://doi.org/10.1038/s41386-021-01142-y

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34400781

Fields of Study

Neurotransmitter Receptor Influence on BehaviorAlcoholism and Thiamine DeficiencyNeuroscience and Neuropharmacology Research

MeSH Terms

AlcoholismBaclofenHumansReceptors, GABA-BGABA AgonistsGABA-B Receptor Agonists

Keywords

BaclofenAgonistAlcohol use disorderGABAB receptorPsychologyAlcoholNeurosciencePharmacologyReceptorMedicineInternal medicineChemistryBiochemistry

Sustainable Development Goals

SDG 0: Good health and well-being

Related Papers (2)

Delving into the reducing effects of the GABAB positive allosteric modulator, KK-92A, on alcohol-related behaviors in rats

Alcohol(2023)

co-cited

10.1016/j.alcohol.2023.07.004

A phase 1b study to investigate the potential interactions between ASP8062 and buprenorphine/naloxone in patients with opioid use disorder

N/A

0.250DataRank · unranked

Journal of Psychopharmacology(2023)

co-cited

10.1177/02698811221149657